BI-93

N/A

Report date: 2025/01/26 16:20:30
NME

Base Information

Drug NameBI-93
Drug Alias Namephosphoglycerate dehydrogenase inhibitor (Boehringer Ingelheim)BI-93
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionD-3-phosphoglycerate dehydrogenase inhibitors
TargetsD-3-phosphoglycerate dehydrogenase
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A